Now I have all I need. Here is the focused, exam-ready LAQ answer on NVBDCP - Malaria from Park's, structured specifically as an LAQ with nothing missing:
NVBDCP - MALARIA
[LAQ Answer - Park's Textbook of Preventive and Social Medicine]
INTRODUCTION
The National Vector Borne Disease Control Programme (NVBDCP) was established in 2002 to control six vector-borne diseases. Malaria is its most important component. The Directorate of NVBDCP under the Ministry of Health & Family Welfare is the nodal agency. The programme is now focused on elimination of malaria, not just control.
MILESTONES OF MALARIA CONTROL IN INDIA
| Year | Milestone |
|---|
| Pre-1953 | 75 million cases; 0.8 million deaths annually |
| 1953 | National Malaria Control Programme (NMCP) launched - 1st Five Year Plan |
| 1958 | NMCP converted to National Malaria Eradication Programme (NMEP) |
| 1965 | Cases reduced to 0.1 million (near-eradication success) |
| Early 1970s | Resurgence of malaria |
| 1976 | Cases peaked at 6.46 million |
| 1977 | Modified Plan of Operations implemented |
| 1997 | World Bank assisted Enhanced Malaria Control Project (EMCP) |
| 1999 | Renamed to National Anti-Malaria Programme (NAMP) |
| 2002 | Renamed to National Vector Borne Disease Control Programme (NVBDCP) |
| 2005 | Global Fund IMCP launched; NVBDCP integrated into NRHM; RDT introduced |
| 2006 | ACT introduced in chloroquine-resistant falciparum areas |
| 2008 | ACT extended to high Pf districts (~95% Pf cases); World Bank National Malaria Control Project |
| 2009 | LLINs introduced |
| 2010 | New Drug Policy 2010 |
| 2012 | Bivalent RDT introduced (detects both P. vivax and P. falciparum) |
| 2013 | New Drug Policy 2013 (no presumptive treatment) |
| 2016 | National Framework for Malaria Elimination in India 2016-2030 launched |
| 2017 | National Strategic Plan for Malaria Elimination 2017-2022 launched |
ADMINISTRATIVE STRUCTURE
| Level | Responsibility |
|---|
| Central | Directorate of NVBDCP - policy, planning, guidelines, monitoring |
| State | State Health Directorates, Programme officers (SDOs) |
| District | CMO/DHO; District Malaria Officer (DVBDC); AMO + Malaria Inspectors |
| PHC | Medical Officer - surveillance, lab services, spray supervision |
| Community | MPWs, ASHAs, community health volunteers |
- Laboratories decentralized to PHC level
- District Vector Borne Disease Control Societies (merged with District Health Societies under NRHM) manage funds and planning
THREE-PRONGED STRATEGY
(i) Disease Management
- Early case detection and complete treatment
- Strengthening referral services
- Epidemic preparedness and rapid response
(ii) Integrated Vector Management (IVM)
- IRS (Indoor Residual Spray) - primary method in rural areas
- Anti-larval measures - primary method in urban areas
- ITNs / LLINs - scaled up to eventually replace IRS
- Larvivorous fish, environmental engineering, source reduction
(iii) Supportive Interventions
- Behaviour Change Communication (BCC)
- Capacity building / Human resource development
- Operational research (drug resistance, insecticide susceptibility)
- Web-based Management Information System
- Public-private partnerships, inter-sectoral convergence
NATIONAL FRAMEWORK FOR MALARIA ELIMINATION 2016-2030
Phase-wise Targets
| Year | Target |
|---|
| By 2020 | - 15 States/UTs (Category 1 in 2014) achieve zero indigenous cases; burden reduced 15-20% from 2014 baseline |
| By 2022 | - 26 States/UTs interrupt transmission; zero indigenous cases and deaths; burden reduced 30-35% |
| By 2024 | - ALL States/UTs reduce API to <1 per 1000; 31 States/UTs interrupt transmission |
| By 2026 | - ALL States/UTs interrupt malaria transmission |
| By 2030 | - Entire country sustains zero indigenous cases and deaths for 3 consecutive years; initiate certification of malaria-free status |
District Categorization for Elimination
| Category | Phase | Description |
|---|
| Category 0 | Prevention of re-establishment | Zero indigenous cases achieved; prevent re-introduction |
| Category 1 | Elimination phase | API < 1 |
| Category 2 | Pre-elimination phase | API 1-2 |
| Category 3 | Intensified control phase | API > 2 |
Sub-Centre Level Stratification by API
| Stratum | API |
|---|
| 1 | Zero cases |
| 2 | >0 to <1 |
| 3 | 1 to <2 |
| 4 | 2 to <5 |
| 5 | ≥5 |
- API ≥5: Coverage by LLINs
- API ≥2: Coverage by conventionally treated nets
- Coverage target: >80% by whichever intervention is used
SURVEILLANCE
Active Case Detection (ACD)
- Carried out in rural areas by MPWs/ANMs
- Blood smears collected during fortnightly house visits
Passive Case Detection (PCD)
- Fever cases reporting to:
- Peripheral health volunteers / ASHAs (RDT-based diagnosis)
- Sub-centres, malaria clinics, CHCs
- Secondary and tertiary hospitals
Key Surveillance Facts
- ABER (Annual Blood Examination Rate): Maintained at ~10% nationally
- Microscopy: Gold standard - high sensitivity, specificity, economical in field settings
- RDTs: Introduced 2003; bivalent RDTs (P. vivax + P. falciparum) introduced 2012
- Sentinel surveillance: 1-3 sentinel sites per high-endemic district in large hospitals for recording all outpatient/inpatient malaria cases and deaths
- National reference laboratory: Set up for confirmation; 100% cases notified post-elimination in each State; real-time SMS/e-mail reporting of all positives
Focus Area Surveillance (Elimination Phase)
Strategies 1-13 in elimination phase include:
- Complete case notification made mandatory
- All positive cases confirmed at reference lab
- Focus investigation for each positive case
- Reactive case detection in surrounding households
- Monitoring migrant populations and industrial area populations
- Surveillance of special groups (school children, workplace colleagues, neighbours)
CASE MANAGEMENT
- No presumptive treatment since Drug Policy 2013
- Diagnosis confirmation mandatory before treatment
| Species | Treatment |
|---|
| P. vivax | Chloroquine + 14-day Primaquine (kills hypnozoites) |
| P. falciparum | ACT (Artesunate Combination Therapy) + single-dose Primaquine |
| Severe malaria | Injectable Arteether / Artesunate |
DRUG DISTRIBUTION CENTRES (DDCs) AND FEVER TREATMENT DEPOTS (FTDs)
| Feature | DDC | FTD |
|---|
| Function | Dispense anti-malarials only | Collect blood slides + dispense anti-malarials |
| Manned by | Community voluntary workers | Community voluntary workers |
| Purpose | Supplement surveillance workers | Enhance early case detection |
URBAN MALARIA SCHEME
- Launched 1971 to reduce/interrupt urban malaria
- Currently protects 130 million population in 131 towns in 19 States/UTs
- Urban malaria = 7.4% of total cases and 10.9% of deaths
- Vector breeds in man-made containers: overhead tanks, coolers, tyres, cisterns, flower vases
- Major cities affected: Chennai, Vadodara, Visakhapatnam, Ahmedabad, Kolkata, Mumbai, Vijayawada
- Control: anti-larval measures, larvivorous fish, civil bye-laws, larvicides
- Civic bye-laws enacted in Delhi, Mumbai, Kolkata, Chandigarh, Bengaluru, Chennai, Ahmedabad
SPECIAL STRATEGY FOR P. VIVAX ELIMINATION
India accounts for >50% of global P. vivax burden. Special challenges:
- Hypnozoites prolong parasite lifespan and are undetectable by RDT
- RDTs for P. vivax are less sensitive than for P. falciparum
- Requires 14-day primaquine therapy (vs. 3 days for P. falciparum)
- Longer incubation period
Strategy: Expand bivalent RDTs; quality microscopy; ensure 14-day treatment compliance; target Anopheles stephensi (urban malaria vector) by anti-larval measures
HIGH-ENDEMIC FOCUS STATES
Andhra Pradesh, Chhattisgarh, Jharkhand, Madhya Pradesh, Maharashtra, Meghalaya, Mizoram, Odisha, Telangana, and Tripura - especially tribal populations in forested/hilly/conflict-affected areas
BCC (BEHAVIOUR CHANGE COMMUNICATION)
Directed at:
- (a) Early recognition of malaria signs/symptoms
- (b) Early treatment seeking from appropriate provider
- (c) Adherence to treatment regimens
- (d) Protection of children and pregnant women
- (e) Use of ITNs/LLINs
- (f) Acceptance of IRS
Anti-Malaria Month: Observed every June (before monsoon/transmission season) - mass media campaigns, inter-sectoral coordination
KEY INDICATORS TO MONITOR PROGRESS (Table 2 of National Framework)
Impact indicators: Confirmed cases (by sex, age, species), severe cases & CFR, malaria in pregnancy, confirmed deaths, number of States in each phase
Outcome indicators: % population sleeping under ITN/LLIN previous night, % protected by IRS in past 12 months, % confirmed cases receiving treatment per guidelines
INTERACTION WITH OTHER PROGRAMMES
| Programme | Interaction |
|---|
| IDSP | Weekly fever alerts provide early warning of malaria outbreaks |
| Dengue control | Overlapping IVM in urban areas |
| Kala-azar control | Overlapping IVM in some Jharkhand districts |
| RCH / ANC | LLINs distributed to pregnant women; Janani Suraksha Yojana provisions |
| IMNCI | Malaria case management norms included |
EXTERNAL SUPPORT
- Global Fund - IMCP II: Round 9, since Oct 2010, 7 North-Eastern states, 86 districts, 46 million population - strategy: early diagnosis + ACT + ITN/LLIN promotion
- World Bank - Malaria Control & Kala-azar Elimination Project: 2009-2013
- World Bank - Enhanced Malaria Control Project (EMCP): 1997
ROLE OF MPW (Male) - MALARIA DUTIES
- Collect thick + thin blood smears from all febrile cases on one glass slide
- Fortnightly visits - collect blood smears from ASHAs/FTDs; replenish drugs, slides, RDKs; check consumption accounts
- Dispatch blood smears with MF-2 form to PHC lab twice a week
- Verify RDK results and radical treatment given by ASHA/FTD
- Administer radical treatment to positive cases per drug schedule; watch for primaquine toxicity
- Inform spray dates; motivate community for spray acceptance
- Assist Health Supervisor in supervising spray operations and training of spray staff
To directly answer your question: YES - for an LAQ on "NVBDCP - Malaria" specifically, the previous answer was not enough because it was missing:
- The full Milestones table (a favourite in exams)
- The Phase-wise targets of the 2016-2030 Framework with exact years and percentages
- The full Category 0, 1, 2, 3 classification with API values
- Full Surveillance detail (ACD vs PCD, ABER, sentinel sites, reference lab)
- The P. vivax special challenges and strategy
- The Anti-Malaria Month (June)
- The Key Indicators table
- All External Projects with details
- The full MPW duties list
This answer above is what a complete LAQ on NVBDCP-Malaria from Park's looks like.